179 related articles for article (PubMed ID: 23638194)
41. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
[TBL] [Abstract][Full Text] [Related]
42. Unraveling Chagas disease transmission through the oral route: Gateways to Trypanosoma cruzi infection and target tissues.
Silva-Dos-Santos D; Barreto-de-Albuquerque J; Guerra B; Moreira OC; Berbert LR; Ramos MT; Mascarenhas BAS; Britto C; Morrot A; Serra Villa-Verde DM; Garzoni LR; Savino W; Cotta-de-Almeida V; de Meis J
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005507. PubMed ID: 28379959
[TBL] [Abstract][Full Text] [Related]
43. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
[TBL] [Abstract][Full Text] [Related]
44. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
45. Melatonin in Chagas' disease. Possible therapeutic value.
Cardinali DP; Alvarez CB
Medicina (B Aires); 2011; 71(5):477-83. PubMed ID: 22057179
[TBL] [Abstract][Full Text] [Related]
46. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
Covarrubias C; Cortez M; Ferreira D; Yoshida N
Int J Parasitol; 2007 Dec; 37(14):1609-16. PubMed ID: 17640647
[TBL] [Abstract][Full Text] [Related]
47. L-arginine supplementation reduces mortality and improves disease outcome in mice infected with Trypanosoma cruzi.
Carbajosa S; Rodríguez-Angulo HO; Gea S; Chillón-Marinas C; Poveda C; Maza MC; Colombet D; Fresno M; Gironès N
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006179. PubMed ID: 29337988
[TBL] [Abstract][Full Text] [Related]
48. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4.
Planagumà A; Titos E; López-Parra M; Gaya J; Pueyo G; Arroyo V; Clària J
FASEB J; 2002 Dec; 16(14):1937-9. PubMed ID: 12368230
[TBL] [Abstract][Full Text] [Related]
49. In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection.
Tonelli RR; Torrecilhas AC; Jacysyn JF; Juliano MA; Colli W; Alves MJ
Parasitology; 2011 Apr; 138(4):481-92. PubMed ID: 21040619
[TBL] [Abstract][Full Text] [Related]
50. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
51. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN
J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710
[TBL] [Abstract][Full Text] [Related]
52. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
[TBL] [Abstract][Full Text] [Related]
53. Potential Role of Carvedilol in the Cardiac Immune Response Induced by Experimental Infection with
Horta AL; Leite AL; Paula Costa G; Figueiredo VP; Talvani A
Biomed Res Int; 2017; 2017():9205062. PubMed ID: 28377930
[No Abstract] [Full Text] [Related]
54. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4).
Titos E; Chiang N; Serhan CN; Romano M; Gaya J; Pueyo G; Clària J
Am J Physiol; 1999 Nov; 277(5):C870-7. PubMed ID: 10564079
[TBL] [Abstract][Full Text] [Related]
55. Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against
Gamba JC; Roldán C; Prochetto E; Lupi G; Bontempi I; Poncini CV; Vermeulen M; Pérez AR; Marcipar I; Cabrera G
Front Cell Infect Microbiol; 2021; 11():671104. PubMed ID: 34295832
[No Abstract] [Full Text] [Related]
56. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi.
Hoft DF; Schnapp AR; Eickhoff CS; Roodman ST
Infect Immun; 2000 Jan; 68(1):197-204. PubMed ID: 10603388
[TBL] [Abstract][Full Text] [Related]
57. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
[TBL] [Abstract][Full Text] [Related]
58. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
[TBL] [Abstract][Full Text] [Related]
59. Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele elicits attenuated Chagas' disease in mice.
Garzón E; Borges MC; Cordeiro-da-Silva A; Nacife V; Meirelles Mde N; Guilvard E; Bosseno MF; Guevara AG; Brenière SF; Ouaissi A
Immunol Lett; 2003 Oct; 89(1):67-80. PubMed ID: 12946866
[TBL] [Abstract][Full Text] [Related]
60. Protection of vascular endothelium by aspirin in a murine model of chronic Chagas' disease.
Molina-Berríos A; Campos-Estrada C; Lapier M; Duaso J; Kemmerling U; Galanti N; Ferreira J; Morello A; López-Muñoz R; Maya JD
Parasitol Res; 2013 Jul; 112(7):2731-9. PubMed ID: 23681190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
